This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.
All articles listed are open access unless stated otherwise.
Therapy
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19.
Science:2021: November 2 Full text
A Phase 2a clinical trial of Molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus.
Science:2021: December 23 Full text
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern.
BioRxiv:2021: December 28 Full text
Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial.
Lancet:2021: December 15 Full text
The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID-19: A meta-analysis of randomized trials.
Immunity, Inflammation and Disease:2021: December 30 Full text
Clinical Practice
Increasing ICU capacity to accommodate higher demand during the COVID-19 pandemic. SVHA
Medical Journal of Australia:2021: October 12 Full text
Physiotherapy management for COVID-19 in the acute hospital setting and beyond: an update to clinical practice recommendations. SVHA
Journal of Physiotherapy:2021: December 23 Full text
Key considerations for elective surgery in patients who previously had COVID-19.
AORN Journal:2021: December 27 Full text
Arteriovenous blood gas agreement for intensive care unit patients with COVID-19.
Australasian Emergency Medicine:2021: January 3 Full text
Relative communicators: evaluation of an innovative hospital role emerging from the Covid-19 pandemic.
Journal of Communication in Healthcare:2021: December 29 Full text
Remote digital urinalysis with smartphone technology as part of remote management of glomerular disease during the SARS-CoV-2 virus pandemic: single centre experience in 25 patients.
Clinical Kidney Journal:2021: December 21 Full text
Pathophysiology and Epidemiology
Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 omicron wave compared with previous waves.
JAMA:2021: December 29 Full text
Neurological issues in children with COVID-19.
Neuroscience Letters:2021: December 19 Full text
Long Covid
Assessment and characterisation of post-COVID-19 manifestations.
International Journal of Clinical Practice:2021: September 29 Full text
Infection Control
Biosensor detection of airborne respiratory viruses such as SARS-CoV-2.
SLAS Technology:2022: January 2 Full text
COVID-19 screening: use of an artificial neural network.
BMJ Supportive and Palliative Care:2021: December 31 Full text
Vaccines
Vaccines elicit highly cross-reactive cellular immunity to the SARS-CoV-2 Omicron variant.
medRxiv:2022: January 3 Full text
Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants.
medRxiv:2022: January 1 Full text
Effect of Covid-19 vaccination on transmission of alpha and delta variants.
New England Journal of Medicine:2022: January 5 Full text
Immunology
Complement activation induces excessive T cell cytotoxicity in severe COVID-19.
Cell:2021: December 28 Full text
Preferential expansion upon boosting of cross-reactive “pre-existing” switched memory B cells that recognize the SARS-CoV-2 Omicron variant Spike protein.
medRxiv:2022: January 1 Full text
The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism.
medRxiv:2022: January 3 Full text
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.
Cell:2022: January 3 Full text
Research
Global analysis of the COVID-19 research landscape and scientific impact.
American Journal of Infection Control:2022: January 2 Full text
